Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
38 "Jong-Koo Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Editorials
The Republic of Korea’s post-COVID-19 pandemic preparedness: it is time to assess the progress of pandemic preparedness
Jong-Koo Lee
Osong Public Health Res Perspect. 2025;16(2):91-93.   Published online April 29, 2025
DOI: https://doi.org/10.24171/j.phrp.2025.0132
  • 684 View
  • 29 Download
PDF
It is time to hold discussions with policymakers
Jong-Koo Lee
Osong Public Health Res Perspect. 2025;16(1):1-2.   Published online February 27, 2025
DOI: https://doi.org/10.24171/j.phrp.2025.0057
  • 536 View
  • 34 Download
PDF
The urgency of improving research infrastructure and institutional frameworks for the next pandemic
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(6):477-478.   Published online December 30, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0361
  • 850 View
  • 143 Download
PDF
Review Article
Comparison and consideration of vaccine injury compensation programs in the Republic of Korea, Japan, and Taiwan
Cho Ryok Kang, Young June Choe, Jihyun Moon, Dooyoung Kim, Taemi Kim, Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(6):479-488.   Published online November 12, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0129
  • 2,078 View
  • 83 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
This study aimed to establish a foundation for future collaborations aimed at preparing for and responding to infectious diseases by examining the vaccine injury compensation programs (VICPs) of East Asian countries. We reviewed the current status of VICPs in the Republic of Korea, Japan, and Taiwan by searching national government websites and reviewing relevant literature. Additionally, we conducted email inquiries targeting experts from Japan and Taiwan. Through the comprehensive analysis of VICPs in these 3 countries covered various aspects, we identified several similarities and differences in the VICPs across these countries. While the governments of the Republic of Korea, Japan, and Taiwan play a central role in supporting investigations into vaccine injuries and managing compensation procedures based on legal statutes, they differ in terms of financial resources for compensation, the range of vaccines covered, and the criteria for assessing causality. In the Republic of Korea, Japan, and Taiwan, compensation is typically paid in a lump sum, although the specific benefits available vary by country. This study on VICPs in the Republic of Korea, Japan, and Taiwan provides valuable insights for the further development and management of domestic systems.
Editorials
Which infectious diseases are currently posing problems in the Republic of Korea? One out of every two tuberculosis patients is over 65 years old
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(5):383-384.   Published online October 31, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0301
  • 668 View
  • 187 Download
PDF
Preparedness for the recent increase in COVID-19 cases
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(4):265-266.   Published online August 29, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0236
  • 1,043 View
  • 167 Download
PDF
Strengthening the health system, including innovative budget mobilization, is an urgent issue for the Expanded Programme on Immunization
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(3):187-188.   Published online June 27, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0181
  • 1,635 View
  • 178 Download
PDF
Peacetime preparedness for the vaccine adverse event
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(2):95-96.   Published online April 30, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0113
  • 1,575 View
  • 159 Download
PDF
Special Article
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health Res Perspect. 2024;15(2):97-106.   Published online April 4, 2024
DOI: https://doi.org/10.24171/j.phrp.2023.0343
  • 3,832 View
  • 127 Download
  • 4 Web of Science
  • 3 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination. This initiative was requested by the Korea Disease Control and Prevention Agency and led by the National Academy of Medicine of Korea. In September 2022, the COVID-19 Vaccine Safety Research Center was established, strengthening CoVaSC’s initiatives. The center has conducted various studies on the safety of COVID-19 vaccines. During CoVaSC’s second research year, from September 29, 2022 to July 19, 2023, the center was restructured into 4 departments: Epidemiological Research, Clinical Research, Communication & Education, and International Cooperation & Policy Research. Its main activities include (1) managing CoVaSC and the COVID-19 Vaccine Safety Research Center, (2) surveying domestic and international trends in AE causality investigation, (3) assessing AEs following COVID-19 vaccination, (4) fostering international collaboration and policy research, and (5) organizing regular fora and training sessions for the public and clinicians. Causality assessments have been conducted for 27 diseases, and independent research has been conducted after organizing ad hoc committees comprising both epidemiologists and clinical experts on each AE of interest. The research process included protocol development, data analysis, interpretation of results, and causality assessment. These research outcomes have been shared transparently with the public and healthcare experts through various fora. The COVID-19 Vaccine Safety Research Center plans to continue strengthening and expanding its research activities to provide reliable, high-quality safety information to the public.

Citations

Citations to this article as recorded by  
  • Risk of new-onset polymyalgia rheumatica following COVID-19 vaccination in South Korea: a self-controlled case-series study
    Jieun Woo, Mu Kyung Kim, HyunJoo Lim, Ju Hwan Kim, Hyunah Jung, Hyoun-Ah Kim, Ju-Young Shin
    RMD Open.2025; 11(2): e005138.     CrossRef
  • SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review
    Avraham Ishay, Kira Oleinikov, Elena Chertok Shacham
    Vaccines.2024; 12(7): 750.     CrossRef
  • Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea
    Bomi Park, Hye Ah Lee, Yeonjae Kim, Chung Ho Kim, Hyunjin Park, Seunghee Jun, Hyelim Lee, Seunghyun Lewis Kwon, Yesul Heo, Hyungmin Lee, Hyesook Park
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
Editorials
What are the strategies for national health security in preparation for the next pandemic?
Jong-Koo Lee
Osong Public Health Res Perspect. 2024;15(1):1-2.   Published online February 28, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0056
  • 1,644 View
  • 211 Download
PDF
How to transform the medical care system after the COVID-19 pandemic
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(6):439-440.   Published online December 28, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0382
  • 1,610 View
  • 172 Download
  • 1 Web of Science
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Streamlining emergency nursing care post-pandemic: A lean approach for reducing wait times and improving patient and staff satisfaction in the hospital
    Azza Hassan Mohamed Hussein, Ebtsam Aly Omer Abou Hashish, Basmaa Ahmed Abd-Elghaffar, Nancy Sabry Hassan Elliethey
    BMC Nursing.2025;[Epub]     CrossRef
To combat COVID-19 and prepare for future pandemics, public trust and communication are essential
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(5):329-332.   Published online October 31, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0317
  • 2,140 View
  • 162 Download
  • 1 Web of Science
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Análisis bibliométrico sobre publicación en estudios de comunicación en revistas científicas latinoamericanas durante el período de 2020 a 2023
    Felipe Anderson Rios Incio, Ángel Páez Moreno, Luis Ernesto Paz Enrique
    Biblios Journal of Librarianship and Information S.2024; (87): e001.     CrossRef
How we can prevent a resurgence this year
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(4):233-234.   Published online August 30, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0235
  • 1,563 View
  • 163 Download
PDF
Neglected issues related to the COVID-19 pandemic
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(3):149-150.   Published online June 30, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.14.3.01
  • 1,801 View
  • 77 Download
PDF
To become a more stronger and safer country
Jong-Koo Lee
Osong Public Health Res Perspect. 2023;14(2):67-69.   Published online April 28, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0105
  • 1,871 View
  • 63 Download
PDF

PHRP : Osong Public Health and Research Perspectives
TOP